Home Newsfeeds Karuna Therapeutics Q3 EPS $(2.38) Down From $(1.72) YoY

Karuna Therapeutics Q3 EPS $(2.38) Down From $(1.72) YoY

Karuna Therapeutics (NASDAQ:KRTX) reported quarterly losses of $(2.38) per share. This is a 38.37 percent decrease over losses of $(1.72) per share from the same period last year.

byBenzinga Newsdesk

November 3, 2022

1 minute read

Karuna Therapeutics (NASDAQ:KRTX) reported quarterly losses of $(2.38) per share. This is a 38.37 percent decrease over losses of $(1.72) per share from the same period last year.

Baird Initiates Coverage On Mister Car Wash with Neutral Rating, Announces Price Target of $10

By Benzinga Newsdesk

October 4, 4:56 AM

Baird analyst Justin Kleber initiates coverage on Mister Car Wash (NYSE:MCW) with a Neutral rating and announces Price Target of $10.

MCW

Needham Maintains Buy on SMART Glb Hldgs, Lowers Price Target to $30

By Benzinga Newsdesk

October 5, 6:39 AM

Needham analyst Rajvindra Gill maintains SMART Glb Hldgs (NASDAQ:SGH) with a Buy and lowers the price target from $40 to $30.

SGH

Earnings

Sarepta Therapeutics Earnings Preview

By Benzinga Insights

August 1, 10:26 AM

Sarepta Therapeutics (NASDAQ:SRPT) is set to give its latest quarterly earnings report on Tuesday, 2022-08-02. Here's what investors need to know before the announcement. Analysts estimate that Sarepta Therapeutics will report an earnings per share (EPS) of $-1.18.

SRPT